OCEANIC AF – Asundexian is inferior to apixaban for stroke prevention in patients with atrial fibrillation
Key Points: Factor XIa inhibition may reduce stroke risk while causing bleeding. In this phase III trial, asundexian, a factor XIa inhibitor, was associated with... Read more.
Edoxaban Monotherapy Associated with Better Net Clinical Benefit than Edoxaban Plus Single Antiplatelet in Patients with AF and Stable CAD: EPIC-CAD
Key Points: In patients with stable coronary artery disease and atrial fibrillation, multiple society guidelines recommend the use of monotherapy with oral anticoagulants... Read more.
STEEER-AF: A Structured Educational Program for Clinicians Improved Adherence to Guideline Recommendation in AF
Key Points: Adherence to guideline recommendations for AF management is suboptimal. STEEER-AF, the first randomized trial conducted by the ESC, assigned treatment... Read more.
IVORY FINALE: Low-Dose IL-2 Reduces Arterial Inflammation after ACS
Key Points: While inflammation is critical to the pathogenesis of atherosclerosis, few available anti-inflammatory treatments have been tested in ACS. In IVORY FINALE,... Read more.
QUADRO – Quadruple Polypill More Effective In Lowering Blood Pressure Than Taking Three Separate Medications in Resistant Hypertension
Key Points: Treatment of resistant hypertension often involves at least three or more medications, but non-adherence increases as the number of pills increases.... Read more.
A Single Combined Measure Of hsCRP, LDL-C, And Lp(A) Predicts Incident CV Events Over 30 Years Among Women’s Health Study Participants
Key Points: While drug trials evaluate the short-term cardiovascular risk associated with elevated, blood biomarkers, little is known about the long term (20-30... Read more.
ASSURE DES: No Difference In Ischemic Events If Aspirin Is Interrupted Or Continued In Patients With DES Undergoing Non-Cardiac Surgery
Key Points: Anti-platelet therapy after coronary drug eluting stent (DES) placement reduces the risk of future ischemic events, but the risk of in-stent thrombosis... Read more.
Morning vs. evening dosing of blood pressure meds: No differences in outcomes or safety for either community-dwelling adults or frail nursing home residents
Key Points: Blood pressure follows a circadian rhythm, peaking after waking and dipping during sleep. While elevated nocturnal pressures are associated with adverse... Read more.
NOTION-3: Revascularization in Patients Undergoing TAVI Associated with Lower Risk of MACE vs Conservative Treatment
Key Points: The NOTION-3 trial found that FFR-guided revascularization with PCI in TAVI patients with coronary artery disease significantly reduced the composite... Read more.
TAVI Superior to Surgical Aortic Valve Replacement in Women: RHEIA Trial
Key Points: The RHEIA trial found that TAVI was superior to surgical aortic valve replacement (SAVR) in women with severe aortic stenosis, significantly reducing... Read more.
